An spike-accum® bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity

An spike-accum® bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity

Summary: Despite the recent control of COVID-19, the devastating effects caused by the 3-year pandemic highlight the importance of developing effective vaccines to rapidly address future outbreaks. The present study describes a novel Spike (Sp) protein-based vaccine formulation using the Accum® plat...

Full description

Saved in:
Bibliographic Details
Main Authors: Jean Pierre Bikorimana, Nathanael A. Caveney, Nehme EL-Hachem, Gabrielle A. Mandl, John A. Capobianco, Daniela Stanga, Jamilah Abusarah, Mark A. Hancock, Roudy Farah, Marina P. Gonçalves, Darryl Falzarano, Mingmin Liao, Glenn Hamonic, Qiang Liu, Simon Beaudoin, Sebastien Talbot, Moutih Rafei
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:iScience
Subjects:
Natural sciences
Biological sciences
Immunology
Immune response
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004225015755
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2589004225015755

Similar Items